Third, all pricing is published on the website before you ever schedule
This promising approach addresses the growing need for alternative treatment strategies in type 2 diabetes management
Lilly has the following drugs in launch and late phase programs: Tirzepatide Orforglipron Eloralintide Retatrutide Brenipatide These products, along with six additional clinical stage programs and 34 discovery programs, have the potential to help 1 billion people across the following indications: Obesity Diabetes Obstructive sleep apnea Pain Cardiovascular Renal Hepatic During the Q&A portion of the presentation, Ricks responded to a question about his key takeaways from 2025 by saying, We think about both market growth and Lily's position within the US market
At InjectCo, compounded GLP-1 medications are only prescribed when clinically appropriate as part of a structured, physician-guided weight loss program
This makes it easier for many patients to stick with healthier eating habits
Substance use, including tobacco, alcohol, opioid, and illicit drug use disorders, should be addressed to maximize GLP1 benefits
